Journal profile · Radiology, Nuclear Medicine & Medical Imaging
European Journal of Nuclear Medicine and Molecular Imaging
ISSN 1619-7070 · eISSN 1619-7089 · Springer Berlin Heidelberg · GERMANY · Monthly · Founded 1976
European Journal of Nuclear Medicine and Molecular Imaging: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 7.51; hybrid open access; APC about USD 3,490; median 72 days to acceptance (116 articles, last 24 months); community-reported acceptance: about 75%; 665 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
European Journal of Nuclear Medicine and Molecular Imaging is published by Springer Berlin Heidelberg and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications and Cardiac Imaging and Diagnostics, together about 40.3% of its articles. Its main subfields are Radiology, Nuclear Medicine and Imaging. (generated from OpenAlex topic counts and CAS ranking data)
The aim of the European Journal of Nuclear Medicine and Molecular Imaging is to provide a forum for the exchange of clinical and scientific information for the imaging community and allied professions involved in the functional, metabolic and molecular investigation of diseases. The European Journal of Nuclear Medicine and Molecular Imaging will remain of primary interest to those practicing the field of imaging, radiopharmaceutical therapy and image guided therapy. The field of interest includes advanced imaging analyses techniques and artificial intelligence application in the field of imaging. Reports on original works related to physics, dosimetry, radiation biology, radiochemistry and pharmacy, will be considered in the field of interest of the EJNMMI. The Journal will welcome original material reflecting the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies.The Journal will continue to publish in depth Reviews of topical interest, Short communications, Controversies, interesting images and Letters to the editor. Case reports are not published. The journal publishes the following article types: Original article Review article Letter to the Editor Guidelines Controversies Image of the month Short Communications Editorials
From the journal's Aims & Scope
Research area (LetPub): Radiology, Nuclear Medicine & Medical Imaging
Editor-in-chief Ignasi CarrioPublisher website
Editorial board by country: 33 in mainland China (about 16%); most named Mainland China 33, Italy 25, United States 21, Germany 20, Netherlands 15 (210 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medical Imaging Techniques and ApplicationsMedicine19.8%
- Radiopharmaceutical Chemistry and ApplicationsMedicine13.8%
- Cardiac Imaging and DiagnosticsMedicine6.7%
- Radiomics and Machine Learning in Medical ImagingMedicine6.1%
- Medical Imaging and Pathology StudiesMedicine4.5%
- Prostate Cancer Treatment and ResearchMedicine4.5%
- Advanced MRI Techniques and ApplicationsMedicine4.3%
- Neuroendocrine Tumor Research AdvancesMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EI CompendexMEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.51LetPub ·
- Impact factor (publisher) 2025
- 7.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 7.9Publisher website ·
- CiteScore 2026-06
- 13.5LetPub ·
- SJR 2026-06
- 2.17LetPub ·
- SNIP 2026-06
- 2.14LetPub ·
- h-index
- 153LetPub ·
- h-index
- 224OpenAlex ·
- i10-index
- 7,864OpenAlex ·
- 2-year mean citedness
- 4.99OpenAlex ·
- Self-citation rate
- 10.5%LetPub ·
- Share of gold OA articles
- 47.15%LetPub ·
Volume
- Articles per year
- 550LetPub ·
- Downloads per year (publisher) 2025
- 3,700,000Publisher website ·
Articles by year OpenAlex count · 14,489 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 487 | 247 | 216 |
| 2025 | 665 | 352 | 2,854 |
| 2024 | 466 | 272 | 5,006 |
| 2023 | 488 | 303 | 8,467 |
| 2022 | 435 | 268 | 12,351 |
| 2021 | 524 | 338 | 20,199 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
72 daysMedian, submission to acceptance · P25–P75 54 days – 91 days
- Acceptance to online
- median 16 days (116 articles)
- Submission to online
- median 90 days
- Sample
- 116 articles with submission and acceptance dates (1,262 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,490 / EUR 5,190 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 6,000 words
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Cover letter
- Required
- Not considered
- pre-evaluation
Article types accepted8, with length limits
- commentaryPlease note that the journal does not offer pre-evaluation. Therefore please directly submit your manuscript to EditorialManager at the Link below. The Editor-i…Length not stated
- editorialPlease note that the journal does not offer pre-evaluation. Therefore please directly submit your manuscript to EditorialManager at the Link below. The Editor-i…Length not stated
- letter to the editorPlease note that the journal does not offer pre-evaluation. Therefore please directly submit your manuscript to EditorialManager at the Link below. The Editor-i…Length not stated
- meta-analysisPlease note that the journal does not offer pre-evaluation. Therefore please directly submit your manuscript to EditorialManager at the Link below. The Editor-i…Length not stated
- original articlePlease note that the journal does not offer pre-evaluation. Therefore please directly submit your manuscript to EditorialManager at the Link below. The Editor-i…main text ≤ 6,000 words
- reviewPlease note that the journal does not offer pre-evaluation. Therefore please directly submit your manuscript to EditorialManager at the Link below. The Editor-i…Length not stated
- short communicationPlease note that the journal does not offer pre-evaluation. Therefore please directly submit your manuscript to EditorialManager at the Link below. The Editor-i…main text ≤ 1,500 words
- systematic reviewPlease note that the journal does not offer pre-evaluation. Therefore please directly submit your manuscript to EditorialManager at the Link below. The Editor-i…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
4 to 6 keywords for indexing Model summary
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data Availability
Optional data availability statement Model summary
This journal encourages authors to provide an optional statement of data availability in their article. Data Availability Statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether …
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
Clinical trial registration required Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in European Journal of Nuclear Medicine and Molecular Imaging, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Berlin Heidelberg
- Country or region
- GERMANY
- Language
- English
- Frequency
- Monthly
- Founded
- 1976
- ISSN
- 1619-7070
- Electronic ISSN
- 1619-7089
- Latest issue on the website
- Volume 53, Issue 11 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about European Journal of Nuclear Medicine and Molecular Imaging
What CAS zone is European Journal of Nuclear Medicine and Molecular Imaging in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Journal of Nuclear Medicine and Molecular Imaging is in Zone 1 of Medicine, and in Zone 1 of the minor category Radiology, Nuclear Medicine & Medical Imaging; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Journal of Nuclear Medicine and Molecular Imaging?
The latest impact factor listed by LetPub is 7.51; CiteScore 13.5, h-index 224.
How long does peer review take at European Journal of Nuclear Medicine and Molecular Imaging?
Based on the dates recorded on 116 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 72 days (interquartile range 54–91 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of European Journal of Nuclear Medicine and Molecular Imaging?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 6,000 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of European Journal of Nuclear Medicine and Molecular Imaging based?
Of the 210 board members whose country the journal's board page names, 33 (about 16%) are in mainland China; the countries named most often are Mainland China (33), Italy (25) and United States (21). Counted from the institutions listed on the board page; for reference only.
Which databases index European Journal of Nuclear Medicine and Molecular Imaging?
According to LetPub and DOAJ records, European Journal of Nuclear Medicine and Molecular Imaging is indexed in SCIE and Scopus. The journal's website also lists EI Compendex, MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is European Journal of Nuclear Medicine and Molecular Imaging open access, and what is the APC?
European Journal of Nuclear Medicine and Molecular Imaging is a hybrid journal. For open-access publication: APC about USD 3,490.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .